Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01376414 · ClinicalTrials.gov registry record

H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department

A clinical trial of Gastritis and Peptic Ulcer, sponsored by George Washington University.

Completed
Registry status
212
Enrollment target
2
Study locations

NCT01376414: Completed study of Gastritis and Peptic Ulcer, sponsored by George Washington University.

NCT01376414 is a study of Gastritis and Peptic Ulcer that has completed, run by George Washington University. The registered enrollment target is 212 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01376414, a study of Gastritis and Peptic Ulcer, has completed, sponsored by George Washington University.

COMPLETED
Registry status
212 participants
Enrollment target
2
Study locations

Study Summary

This pilot study aims to estimate the prevalence of Helicobacter pylori (H. pylori) colonization in patients presenting with non-specific abdominal pain (NSAP) in an urban academic emergency department (ED) located in Washington, DC.

Primary Outcome

Prevalence of H. pylori infection diagnosed by UBT in patients with symptomatic upper abdominal pain treated in the ED.

Interventions

  • OTHER Urea Breath Test (UBT) for H. pylori infection

Study Locations (2)

District of Columbia

  • George Washington University Hospital - Washington D.C.
  • GWU Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2011-03
Est. Completion 2015-03
George Washington University

133 total trials

What the finished NCT01376414 record still lists

NCT01376414 is an observational study that tracks outcomes without assigning an intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap.

The record links to 4 conditions, with Gastritis appearing as the primary indexed condition, and to 1 intervention - of which Urea Breath Test (UBT) for H. pylori infection is the first listed.

NCT01376414 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01376414 about?

NCT01376414 is a clinical study titled "H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department". This pilot study aims to estimate the prevalence of Helicobacter pylori (H. pylori) colonization in patients presenting with non-specific abdominal pain (NSAP) in an urban academic emergency department (ED) located in Washington, DC.

What is the current status of trial NCT01376414?

This trial is currently completed. The enrollment target is 212 participants. The study started on 2011-03. Estimated completion is 2015-03.

What conditions does trial NCT01376414 study?

This clinical trial studies the following conditions: Gastritis, Peptic Ulcer, Stomach Ulcer, Peptic Ulcer Perforation.

What interventions are being tested in trial NCT01376414?

The interventions under investigation include: Urea Breath Test (UBT) for H. pylori infection (OTHER).

Who is sponsoring clinical trial NCT01376414?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01376414 being conducted?

This trial has 2 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

  • NCT06456593 · 212 participants · Phase 2

    Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01376414, the US trial registry maintained by the National Library of Medicine. NCT01376414 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.